Cargando…

Clinical Data and Biocalculation Methods of GABRD Determine the Clinical Characteristics and Immune Relevance of Colorectal Cancer

BACKGROUND: The aim of this study was to clarify the expression of gamma-aminobutyric acid type A receptor delta subunit (GABRD) gene in pan-cancer and its correlation with patient prognosis, and to investigate the function and possible mechanism of GABRD in colorectal cancer (CRC). METHODS: The Can...

Descripción completa

Detalles Bibliográficos
Autores principales: Bi, Yuhe, Liu, Xinju, Li, Wei, Xu, JiaCheng, Xi, Jie, Wei, Shengchao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9239793/
https://www.ncbi.nlm.nih.gov/pubmed/35774742
http://dx.doi.org/10.1155/2022/6198448
_version_ 1784737382536314880
author Bi, Yuhe
Liu, Xinju
Li, Wei
Xu, JiaCheng
Xi, Jie
Wei, Shengchao
author_facet Bi, Yuhe
Liu, Xinju
Li, Wei
Xu, JiaCheng
Xi, Jie
Wei, Shengchao
author_sort Bi, Yuhe
collection PubMed
description BACKGROUND: The aim of this study was to clarify the expression of gamma-aminobutyric acid type A receptor delta subunit (GABRD) gene in pan-cancer and its correlation with patient prognosis, and to investigate the function and possible mechanism of GABRD in colorectal cancer (CRC). METHODS: The Cancer Genome Atlas (TCGA) data were used to analyze the expression differences of GABRD in pan-cancer, and the correlation between GABRD and clinical prognosis of various tumors was analyzed by Cox regression method. According to the expression level of GABRD, Gene Function Annotation (GO) and Kyoto Encyclopedia of Genomes (KEGG) functional enrichment analysis were performed on the differentially expressed genes. Expression of GABRD gene and 44 marker genes of three types of RNA modification (m1A (10), m5C (13), m6A (21)) genes in different tumors was observed. Pearson correlation of GABRD gene and marker genes of five immune pathways was measured. RESULTS: : TCGA data analysis showed that GABRD was significantly upregulated in various tumor tissues, especially COAD and READCOAD. Survival analysis showed that GABRD was a prognostic protective factor in CRC (p < 0.001). The results of survival nomogram showed that GABRD, age, and tumor (T) lymph node (N) distant metastasis (M) stage were independent prognostic factors, and the survival model C-index was 0.724 (0.644-1). Gene enrichment and functional analysis showed that GABRD may be related to protein digestion and absorption, ECM-receptor interaction, extracellular structure organization, extracellular matrix organization, pancreatic secretion, and antimicrobial humoral response. The expression of GABRD was positively correlated in m1A-, m5C-, and m6A-related genes. The GABRD gene was found in B cell, T cell CD4, T cell CD8, neutrophil, macrophage in TCGA-COAD (N = 282), and TCGA-COADREAD (N = 373). The infiltration level and DC was significantly positively correlated (p < 0.05). Also, the Pearson correlation coefficient is the largest. CONCLUSION: The involvement of GABRD in the occurrence and development of CRC may be related to protein digestion and absorption, ECM-receptor interaction, extracellular structure organization, extracellular matrix organization, pancreatic secretion, and antimicrobial humoral response. GABRD can be used as a molecular marker for the prognosis of CRC.
format Online
Article
Text
id pubmed-9239793
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-92397932022-06-29 Clinical Data and Biocalculation Methods of GABRD Determine the Clinical Characteristics and Immune Relevance of Colorectal Cancer Bi, Yuhe Liu, Xinju Li, Wei Xu, JiaCheng Xi, Jie Wei, Shengchao Evid Based Complement Alternat Med Research Article BACKGROUND: The aim of this study was to clarify the expression of gamma-aminobutyric acid type A receptor delta subunit (GABRD) gene in pan-cancer and its correlation with patient prognosis, and to investigate the function and possible mechanism of GABRD in colorectal cancer (CRC). METHODS: The Cancer Genome Atlas (TCGA) data were used to analyze the expression differences of GABRD in pan-cancer, and the correlation between GABRD and clinical prognosis of various tumors was analyzed by Cox regression method. According to the expression level of GABRD, Gene Function Annotation (GO) and Kyoto Encyclopedia of Genomes (KEGG) functional enrichment analysis were performed on the differentially expressed genes. Expression of GABRD gene and 44 marker genes of three types of RNA modification (m1A (10), m5C (13), m6A (21)) genes in different tumors was observed. Pearson correlation of GABRD gene and marker genes of five immune pathways was measured. RESULTS: : TCGA data analysis showed that GABRD was significantly upregulated in various tumor tissues, especially COAD and READCOAD. Survival analysis showed that GABRD was a prognostic protective factor in CRC (p < 0.001). The results of survival nomogram showed that GABRD, age, and tumor (T) lymph node (N) distant metastasis (M) stage were independent prognostic factors, and the survival model C-index was 0.724 (0.644-1). Gene enrichment and functional analysis showed that GABRD may be related to protein digestion and absorption, ECM-receptor interaction, extracellular structure organization, extracellular matrix organization, pancreatic secretion, and antimicrobial humoral response. The expression of GABRD was positively correlated in m1A-, m5C-, and m6A-related genes. The GABRD gene was found in B cell, T cell CD4, T cell CD8, neutrophil, macrophage in TCGA-COAD (N = 282), and TCGA-COADREAD (N = 373). The infiltration level and DC was significantly positively correlated (p < 0.05). Also, the Pearson correlation coefficient is the largest. CONCLUSION: The involvement of GABRD in the occurrence and development of CRC may be related to protein digestion and absorption, ECM-receptor interaction, extracellular structure organization, extracellular matrix organization, pancreatic secretion, and antimicrobial humoral response. GABRD can be used as a molecular marker for the prognosis of CRC. Hindawi 2022-06-21 /pmc/articles/PMC9239793/ /pubmed/35774742 http://dx.doi.org/10.1155/2022/6198448 Text en Copyright © 2022 Yuhe Bi et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Bi, Yuhe
Liu, Xinju
Li, Wei
Xu, JiaCheng
Xi, Jie
Wei, Shengchao
Clinical Data and Biocalculation Methods of GABRD Determine the Clinical Characteristics and Immune Relevance of Colorectal Cancer
title Clinical Data and Biocalculation Methods of GABRD Determine the Clinical Characteristics and Immune Relevance of Colorectal Cancer
title_full Clinical Data and Biocalculation Methods of GABRD Determine the Clinical Characteristics and Immune Relevance of Colorectal Cancer
title_fullStr Clinical Data and Biocalculation Methods of GABRD Determine the Clinical Characteristics and Immune Relevance of Colorectal Cancer
title_full_unstemmed Clinical Data and Biocalculation Methods of GABRD Determine the Clinical Characteristics and Immune Relevance of Colorectal Cancer
title_short Clinical Data and Biocalculation Methods of GABRD Determine the Clinical Characteristics and Immune Relevance of Colorectal Cancer
title_sort clinical data and biocalculation methods of gabrd determine the clinical characteristics and immune relevance of colorectal cancer
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9239793/
https://www.ncbi.nlm.nih.gov/pubmed/35774742
http://dx.doi.org/10.1155/2022/6198448
work_keys_str_mv AT biyuhe clinicaldataandbiocalculationmethodsofgabrddeterminetheclinicalcharacteristicsandimmunerelevanceofcolorectalcancer
AT liuxinju clinicaldataandbiocalculationmethodsofgabrddeterminetheclinicalcharacteristicsandimmunerelevanceofcolorectalcancer
AT liwei clinicaldataandbiocalculationmethodsofgabrddeterminetheclinicalcharacteristicsandimmunerelevanceofcolorectalcancer
AT xujiacheng clinicaldataandbiocalculationmethodsofgabrddeterminetheclinicalcharacteristicsandimmunerelevanceofcolorectalcancer
AT xijie clinicaldataandbiocalculationmethodsofgabrddeterminetheclinicalcharacteristicsandimmunerelevanceofcolorectalcancer
AT weishengchao clinicaldataandbiocalculationmethodsofgabrddeterminetheclinicalcharacteristicsandimmunerelevanceofcolorectalcancer